Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 1,580 | 9,685 | 7,572 | 41,817 |
| Gross Profit | N/A | 1,580 | 9,685 | 7,572 | 41,817 |
| Operating Expenses | 228,365 | 185,725 | 136,885 | 105,107 | 83,462 |
| Operating Income | -228,365 | -184,145 | -127,200 | -97,535 | -41,645 |
| Interest Expense | 3,024 | 1,267 | 791 | 0 | 0 |
| Other Income | 21,085 | 24,076 | 4,670 | 272 | 112 |
| Pre-tax Income | -210,304 | -161,336 | -123,321 | -97,263 | -41,533 |
| Net Income Continuous | -210,304 | -161,336 | -123,321 | -97,263 | -41,533 |
| Net Income | $-210,304 | $-161,336 | $-123,321 | $-97,263 | $-41,533 |
| EPS Basic Total Ops | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 |
| EPS Basic Continuous Ops | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 |
| EPS Diluted Total Ops | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 |
| EPS Diluted Continuous Ops | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 |
| EPS Diluted Before Non-Recurring Items | -3.47 | -2.75 | -2.94 | -2.71 | -1.95 |
| EBITDA(a) | $-223,730 | $-187,294 | $-127,183 | $-94,738 | $-40,335 |